This inventor holds 1 USPTO granted patent. Top assignee: Glenmark Pharmaceuticals Limited. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: K Eswara Rao: Innovator in Pyrimidine Derivatives
Introduction
K Eswara Rao is a notable inventor based in Navi Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of pyrimidine derivatives. His innovative approach has led to the development of a patented process that enhances the efficiency of synthesizing these important compounds.
Latest Patents
K Eswara Rao holds a patent for a process for the preparation of pyrimidine derivatives. This improved process involves reacting a Wittig reagent with an aldehyde in the presence of a base. The patent outlines the specific chemical structures and conditions necessary for the reaction, showcasing Rao's expertise in organic chemistry and pharmaceutical applications.
Career Highlights
K Eswara Rao is currently employed at Glenmark Pharmaceuticals Limited, a leading global pharmaceutical company. His work at Glenmark has allowed him to focus on innovative drug development and contribute to the advancement of pharmaceutical sciences. His dedication to research and development has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, K Eswara Rao has collaborated with esteemed colleagues such as Narendra Shriram Joshi and Shekhar Bhaskar Bhirud. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
K Eswara Rao's contributions to the field of pyrimidine derivatives exemplify the impact of innovative thinking in pharmaceuticals. His patented process not only enhances the preparation of these compounds but also reflects his commitment to advancing medical science. His work continues to inspire future innovations in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
